Page last updated: 2024-09-03

ly 293558 and Brain Injuries

ly 293558 has been researched along with Brain Injuries in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Apland, JP; Aroniadou-Anderjaska, V; Braga, MF; Figueiredo, TH; Rossetti, K1
Apland, JP; Aroniadou-Anderjaska, V; Braga, MFM; De Araujo Furtado, M; Figueiredo, TH1

Other Studies

2 other study(ies) available for ly 293558 and Brain Injuries

ArticleYear
Delayed tezampanel and caramiphen treatment but not midazolam protects against long-term neuropathology after soman exposure.
    Experimental biology and medicine (Maywood, N.J.), 2023, Volume: 248, Issue:7

    Topics: Animals; Anticonvulsants; Brain; Brain Injuries; Female; Male; Midazolam; Nerve Agents; Rats; Seizures; Soman; Status Epilepticus

2023
Full Protection Against Soman-Induced Seizures and Brain Damage by LY293558 and Caramiphen Combination Treatment in Adult Rats.
    Neurotoxicity research, 2018, Volume: 34, Issue:3

    Topics: Animals; Anticonvulsants; Body Weight; Brain Injuries; Brain Waves; Cholinesterase Inhibitors; Cyclopentanes; Disease Models, Animal; Drug Therapy, Combination; Electroencephalography; Fluoresceins; Fourier Analysis; Isoquinolines; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Seizures; Soman; Tetrazoles; Time Factors

2018